162 related articles for article (PubMed ID: 34433326)
1. Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts.
Tang R; Zhu J; Liu Y; Wu N; Han J
Technol Cancer Res Treat; 2021; 20():15330338211036324. PubMed ID: 34433326
[TBL] [Abstract][Full Text] [Related]
2. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
3. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma.
Lang M; Wang X; Wang H; Dong J; Lan C; Hao J; Huang C; Li X; Yu M; Yang Y; Yang S; Ren H
Cancer Lett; 2016 Aug; 378(2):87-96. PubMed ID: 27212442
[TBL] [Abstract][Full Text] [Related]
5. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide-loaded CalliSpheres:
Duan X; Zhao G; Han X; Ren J; Li H; Chen P; Wang M; Ju S
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982781
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli.
Han JB; Sang F; Chang JJ; Hua YQ; Shi WD; Tang LH; Liu LM
Onco Targets Ther; 2013; 6():1129-38. PubMed ID: 23990729
[TBL] [Abstract][Full Text] [Related]
8. Arsenic Trioxide Inhibits Cell Growth and Invasion via Down- Regulation of Skp2 in Pancreatic Cancer Cells.
Gao JK; Wang LX; Long B; Ye XT; Su JN; Yin XY; Zhou XX; Wang ZW
Asian Pac J Cancer Prev; 2015; 16(9):3805-10. PubMed ID: 25987041
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
Lu J; Jin J; Xu WL
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066
[TBL] [Abstract][Full Text] [Related]
10. Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma.
Zhang F; Duan J; Song H; Yang L; Zhou M; Wang X
Drug Dev Res; 2021 May; 82(3):430-439. PubMed ID: 33244794
[TBL] [Abstract][Full Text] [Related]
11. Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo.
Wahiduzzaman M; Ota A; Karnan S; Hanamura I; Mizuno S; Kanasugi J; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Takami A; Hosokawa Y
Cancer Lett; 2018 Oct; 433():117-130. PubMed ID: 29944906
[TBL] [Abstract][Full Text] [Related]
12. The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude mice.
Yu R; Wang D; Ren X; Zeng L; Liu Y
Leuk Res; 2014 Sep; 38(9):1085-90. PubMed ID: 24908354
[TBL] [Abstract][Full Text] [Related]
13. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
Du S; Liu K; Gao P; Li Z; Zheng J
Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
[TBL] [Abstract][Full Text] [Related]
14. Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells.
Lee PC; Kakadiya R; Su TL; Lee TC
Neoplasia; 2010 May; 12(5):376-87. PubMed ID: 20454509
[TBL] [Abstract][Full Text] [Related]
15.
Chen ZH; Zhang YL; Yuan B; Chen WJ; Lei GY; Han L
Clin Transl Oncol; 2023 Jul; 25(7):2127-2137. PubMed ID: 36723786
[TBL] [Abstract][Full Text] [Related]
16. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
17. Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal.
Kong D; Jiang T; Liu J; Jiang X; Liu B; Lou C; Zhao B; Carroll SL; Feng G
Drug Deliv; 2020 Nov; 27(1):1729-1740. PubMed ID: 33307843
[TBL] [Abstract][Full Text] [Related]
18. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidine Dithiocarbamate Facilitates Arsenic Trioxide Against Pancreatic Cancer via Perturbing Ubiquitin-Proteasome Pathway.
Yu S; Wu N; Zhu J; Liu Y; Han J
Cancer Manag Res; 2020; 12():13149-13159. PubMed ID: 33376406
[TBL] [Abstract][Full Text] [Related]
20. Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation.
Bell JB; Eckerdt F; Dhruv HD; Finlay D; Peng S; Kim S; Kroczynska B; Beauchamp EM; Alley K; Clymer J; Goldman S; Cheng SY; James CD; Nakano I; Horbinski C; Mazar AP; Vuori K; Kumthekar P; Raizer J; Berens ME; Platanias LC
Mol Cancer Res; 2018 Jan; 16(1):32-46. PubMed ID: 29042487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]